Centre de Recherche Médicale de Lambaréné

Quick facts

Marketed products

• Benzimidazole Anthelmintic

Phase 2 pipeline

• Artefenomel-Ferroquine · Infectious Diseases
  Artefenomel-Ferroquine is a combination of artefenomel and ferroquine, which targets the Plasmodium falciparum parasite.
• artesunate-pyronaridine

Phase 1 pipeline

• rVSVΔG-ZEBOV-GP, V920
• Vaccine AnAPN1

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Centre de Recherche Médicale de Lambaréné portfolio CI brief
• Centre de Recherche Médicale de Lambaréné pipeline updates RSS